Publications
5674 Results
- Journal / Conference
- Journal of the American Medical Association, 309(6):578-586;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID23403682
- PMC
- PMC3697935
- Study Number(s)
- S0701
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities
- Journal / Conference
- Cancer Causes and Control 24(2):209-215;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID23263777
- PMC
- PMC3645498
- Study Number(s)
- S0701
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG trial S0701)
- Journal / Conference
- Cancer 119(3):593-601;
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID22893105
- PMC
- PMC3502695
- Study Number(s)
- SWOG-9217
Projecting prostate mortality in the PCPT and REDUCE chemoprevention trials
- Journal / Conference
- Leukemia & Lymphoma 54(2):252-254
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID22897733
The impact of initial fludarabine therapy on transformation to richter's syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)
- Journal / Conference
- Journal of Clinical Oncology 31(13):1662-1668;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23478060
- PMC
- PMC3635682
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, melphalan (BEAM) compared with 131-iodine tositumomab/BEAM with autologous stem cell transplantation for relapsed diffuse large b-cell lymphoma (DLBCL): results from the Blood and Marrow Transplant Clinical Trials Netword (BMT CTN) 0401 trial
- Journal / Conference
- Annals of Oncology 24(6):1587-1593;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23504948
- PMC
- PMC3660082
- Study Number(s)
- S0213
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients < 70 years of age with previously untreated mantle cell lymphoma: SWOG 0213
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 72(5):1089-1096;
- Year
- 2013
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID24057042
- PMC
- PMC4072025
- Study Number(s)
- S0528
Phase I study evaluating the combination of lapatinib and everolimus in patients with advanced cancers: SWOG study S0528
- Journal / Conference
- Annals of Thoracic Surgery 94(6):2172-2175; Society of Thoracic Surgeons 2013 Annual Meeting (Jan 26-30, 2013, Los Angeles, CA), oral presenation;
- Year
- 2013
- Research Committee(s)
- Lung
- Study Number(s)
- S0220
Induction chemoradiotherapy followed by consolidation cytotoxic therapy for superior sulcus (Pancoast tumors) non-small cell lung cancer: a SWOG-coordinated feasibility phase II intergroup trial (S0220)
- Journal / Conference
- New England Journal of Medicine, 369(18):1681-1690;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID24171516
- PMC
- PMC3985418
- Study Number(s)
- S9704
Autologous transplant as consolidation for aggressive non-hodgkin's lymphoma
- Journal / Conference
- Blood 121(24):4854-4860;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID23591789
- PMC
- PMC3682338
- Study Number(s)
- S0106